1/2 cap Twice Daily for Men; Once for Women
Minoxidil is the only FDA approved topical solution for treating androgenetic alopecia (AGA). In 1988 it was first approved for men and in 1992 for women. The early formulations contained propylene glycol which had a tendency to cause irritation. Although the propylene glycol based formulations are still widely available, the introduction of minoxidil foam as "Rogaine foam" in 2006 had many advantages as it was less irritating. Rogaine foam was approved for men in 2006 as a twice daily application of 1/2 cap each time. The FDA approved Rogaine foam in 2014 for women at a dose of 1/2 cap once daily.
Dr. Jeff Donovan is a Canadian and US board certified dermatologist specializing exclusively in hair loss. To schedule a consultation, please call the Whistler office at 604.283.1887